CNBC · Finance · 2026-08-26
Revolution Medicines gets FDA nod for targeted pancreatic cancer drug
The drug is a once-daily pill designed to block several forms of the RAS protein, which helps drive tumor growth in many pancreatic cancers. Revolution Medicines gets FDA nod for targeted pancreatic cancer drug
Read original on CNBC Get the app
Licensed summary · LicensedSummary
Related briefs
- Economists want Warsh to share more on his view of the economy at Jackson
- Stock market prediction tomorrow, 27 August: What will happen to Sensex
- Why we need ‘Human Reserved’ jobs, says Bill Gates—and how we can combat the
- Apple sets iPhone launch event for Sept. 9, first under new CEO John Ternus
- States sue to block Trump-backed USPS mail-ballot rule after Supreme Court